Genetic diversity within Schistosoma haematobium: DNA barcoding reveals two distinct groups. by Webster, Bonnie L et al.
Genetic Diversity within Schistosoma haematobium:
DNA Barcoding Reveals Two Distinct Groups
Bonnie L. Webster1*¤, Aiden M. Emery1, Joanne P. Webster2, Anouk Gouvras1, Amadou Garba3,
Oumar Diaw4, Mohmoudane M. Seye4, Louis Albert Tchuem Tchuente5,6, Christopher Simoonga7,
Joseph Mwanga8, Charles Lange9, Curtis Kariuki9, Khalfan A. Mohammed10, J. Russell Stothard11,
David Rollinson1
1Wolfson Wellcome Biomedical Laboratories, Department of Zoology, Natural History Museum, London, United Kingdom, 2Department of Infectious Disease
Epidemiology, Faculty of Medicine, Imperial College, St Mary’s Campus, London, United Kingdom, 3 Re´seau International Schistosomoses, Environnement, Ame´nagement
et Lutte (RISEAL-Niger), Niamey, Niger, 4 Institut Se´ne´galais de Recherches Agricoles (ISRA), Bel Air, Dakar, Senegal, 5 Laboratoire de Parasitologie et Ecologie, Universite´
de Yaounde´ I, Yaounde´, Cameroon, 6Center for Schistosomiasis and Parasitology, Yaounde´, Cameroon, 7University of Zambia, Lusaka, Zambia, 8National Institute for
Medical Research, Mwanza, Tanzania, 9Department of Invertebrate Zoology, National Museums of Kenya, Nairobi, Kenya, 10Helminth Control Laboratory Unguja,
Ministry of Health and Social Welfare, Zanzibar, Tanzania, 11Disease Control Strategy Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Abstract
Background: Schistosomiasis in one of the most prevalent parasitic diseases, affecting millions of people and animals in
developing countries. Amongst the human-infective species S. haematobium is one of the most widespread causing
urogenital schistosomiasis, a major human health problem across Africa, however in terms of research this human pathogen
has been severely neglected.
Methodology/Principal Findings: To elucidate the genetic diversity of Schistosoma haematobium, a DNA ‘barcoding’ study
was performed on parasite material collected from 41 localities representing 18 countries across Africa and the Indian Ocean
Islands. Surprisingly low sequence variation was found within the mitochondrial cytochrome oxidase subunit I (cox1) and
the NADH-dehydrogenase subunit 1 snad1). The 61 haplotypes found within 1978 individual samples split into two distinct
groups; one (Group 1) that is predominately made up of parasites from the African mainland and the other (Group 2) that is
made up of samples exclusively from the Indian Ocean Islands and the neighbouring African coastal regions. Within Group 1
there was a dominance of one particular haplotype (H1) representing 1574 (80%) of the samples analyzed. Population
genetic diversity increased in samples collected from the East African coastal regions and the data suggest that there has
been movement of parasites between these areas and the Indian Ocean Islands.
Conclusions/Significance: The high occurrence of the haplotype (H1) suggests that at some point in the recent
evolutionary history of S. haematobium in Africa the population may have passed through a genetic ‘bottleneck’ followed
by a population expansion. This study provides novel and extremely interesting insights into the population genetics of S.
haematobium on a large geographic scale, which may have consequence for control and monitoring of urogenital
schistosomiasis.
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Introduction
Schistosomiasis remains one of the world’s greatest neglected
tropical diseases (NTD). Schistosoma haematobium is one of the most
widespread species of Schistosoma and causes urogenital schistoso-
miasis in humans. More people are infected with S. haematobium
than with all the other schistosome species combined. Of the.110
million cases of S. haematobium infection in sub-Saharan Africa, 70
million are associated with hematuria, 18 million with bladder wall
pathology, and 10 million with hydronephrosis leading to severe
kidney disease [1–2] and even bladder cancer [3]. Despite the
enormous numbers of people infected with S. haematobium and the
pathogenesis of the parasite’s infection, empirical studies on S.
haematobium are minimal, compared to those of S. mansoni and S.
japonicum, due, at least in part, to the inherent logistical difficulties
of maintaining S. haematobium within the laboratory system [4].
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However, as the whole-genome sequence of S. haematobium has
recently been published [5], further research into this most
neglected of the NTDs, at least at the genomic level, may now be
facilitated.
S. haematobium has a large geographical distribution being found
throughout Africa, parts of the Middle East, Madagascar and the
Indian Ocean Islands and is transmitted by various intermediate
snail hosts within the genus Bulinus [6]. As yet, the diversity of S.
haematobium has been the subject of very few molecular studies [7–
8], although one earlier study using enzyme analyses by isoelectric
focusing in polyacrylamide gels to study 22 laboratory bred isolates
of S. haematobium showed some regional variation and suggested
mixing of parasite strains due to human population movements
[9]. It remains imperative, however, that more investigations are
conducted to elucidate the extent of genetic variation across the
range of this parasite if we are to realistically understand its
potential evolution, transmission and perhaps ultimate control.
Praziquantel (PZQ) remains the drug of choice for treatment of
schistosomiasis and for the control of morbidity. It has a good
safety and therapeutic record and is easy to administer (single oral
dose), generally improving the health and well-being of schisto-
some-infected people. National control programmes in several
sub-Saharan countries aim to alleviate the burden of schistosomi-
asis in highly endemic areas through large-scale administration of
PZQ [10–13] and are likely to place strong and novel selective
pressures on the parasites, which may be predicted to impact their
population structure and genetics [14–16], [8].
In recent years, developments in molecular tools, and in
particular advances in DNA sequencing, have allowed greater
exploration and recording of the genetic diversity of schistosome
species and their hosts thereof (e.g. [17–18], [16]). Sequence
variation in the mitochondrial cytochrome oxidase sub-unit I (cox1)
gene is commonly compared between sampled specimens to
identify evolutionary differences, as well as, similarities. Such
studies have benefited from knowledge of the complete mitochon-
drial genome of S. haematobium, as well as other schistosomes [19–
21], thereby enhancing population-focused studies [22], [17], [4].
DNA ‘barcoding’ of a large number of populations of S. mansoni to
date has revealed extensive population diversity with geographical
structuring existing between populations [23–24]. A focused study
on primarily laboratory passaged S. haematobium worms from
Zanzibar also revealed substantial genetic diversity with the worms
splitting into two distinct phylogenetic groups [25]. Taking a
similar DNA ‘barcoding’ approach, the aim of this study was to
document the genetic variation of S. haematobium from several areas
geographically spread across Africa using historical collections of
laboratory isolates but also mainly large collections of individual
schistosome miracidia and cercariae sampled directly from their
natural hosts, thereby avoiding the ethical and biological biases
inherent within analyses of laboratory-passaged adult worms [18].
It was expected that the data would reveal any geographical
structuring of the parasite populations and the extent of the genetic
diversity within and between populations across Africa. Also, due
to the wide geographic spread and extensive sampling of
miracidia, primarily from infected school-aged children it was
predicted that the same or more genetic diversity would be found
within and between populations as that found in the study on
Zanzibar [25]. By so doing the origin, evolution and spread of S.
haematobium on the African mainland and the Indian Ocean Islands
could be further elucidated.
Ethical statement
Ethical approval was obtained from Imperial College Research
Ethics Committee (ICREC), Imperial College London in the UK,
in combination with the ongoing Schistosomiasis Control Initiative
(SCI) activities. In Senegal, ethical approval was obtained from the
ethical committees of the Ministry of Health Dakar, Senegal. In
Niger, ethical clearance was obtained from the Niger National
Ethical Committee. In Cameroon, ethical approval was obtained
from the Commite´ National d’Ethique´, Cameroon. In Kenya,
ethical approval was obtained from the Ethical Review Board of
National Museums of Kenya/Kenya Medical Research Institute.
In Tanzania, ethical approval was obtained from the Ethical
Review Board of National Institute of Medical Research (NIMR).
In Zambia, ethical clearance was obtained from the University of
Zambia ethics committee.
Before conducting the study, the MoH-approved plan of action
had been presented and adopted by regional and local adminis-
trative and health authorities. Meetings were held in each village
to inform the village leader, heads of the families, local health
authority, teachers, parents and children about the study, its
purpose and to invite them to voluntarily participate. According to
common practice and with approval from the Imperial College
Research Ethics Committee (ICREC), due to low levels of literacy
all village leaders, teachers, parents and study participants gave
oral consent for the studies to take place. Informed consent for the
urine examinations was obtained from each study participant and
their parents or guardians. Oral consent for each participant was
documented by inscription at school committees comprising of
parents, teachers and community leaders. All the data were
analyzed anonymously and all schistosomiasis positive participants
were treated with PZQ (40 mg/kg). In schools or classes where the
percentage of infections were more than 50%, mass treatment of
all children was carried out at the end of the study.
The historical material stored in SCAN has been derived from
UK laboratory passage of original specimens collected in
collaboration with local authorities abiding by the ethical
standards and collection requirements of the day and all specimens
were maintained and analyzed anonymously.
Laboratory animal use was within a designated facility at the
NHM regulated under the terms of the UK Animals (Scientific
Procedures) Act, 1986, complying with all requirements therein,
Author Summary
Schistosomiasis is a disease caused by parasitic blood
flukes of the genus Schistosoma. Species that infect
humans are prevalent in developing countries, having a
major impact on public health and well-being as well as an
impediment to socioeconomic development. More people
are infected with Schistosoma haematobium than with all
the other schistosome species combined, however mainly
due to the inability to maintain S. haematobium in the
laboratory system empirical studies on this parasite are
minimal. The genetic variation of this Schistosoma species
on a wide geographical scale has never been investigated.
In this study, we have used a DNA ‘barcoding’ approach to
document the genetic variation and population structure
of S. haematobium sampled from 18 countries across Africa
and the Indian ocean Islands. The study revealed a distinct
genetic separation of S. haematobium from the Indian
Ocean Islands and the closely neighbouring coastal
regions from S. haematobium found throughout the
African mainland, the latter of which exhibited extremely
low levels of mitochondrial diversity within and between
populations of parasites sampled. The data from this study
provides a novel insight into the population genetics of S.
haematobium and will have an impact on future research
strategies.
cox1 Diversity of Schistosoma haematobium
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including an internal ethical review process at the NHM and
regular independent Home Office inspection. Work was carried
out under the Home Office project license numbers 70/4687 (-
2003), 70/5935 (2003–2008), 70/6834 (2008-).
Materials and Methods
Sample collections
As part of a European Commission Specific Research Project
(CONTRAST) ‘A multidisciplinary alliance to optimize schisto-
somiasis control and transmission surveillance in sub-Saharan
Africa’, parasitological surveys were conducted at 13 localities in a
total of seven countries across Africa between 2007–2010 (Table
S1). Eggs were sampled directly from urine samples, either
individually or pooled, of infected children. Eggs were concen-
trated from each infected urine sample by sedimentation or
filtration, then rinsed in saline before transfer into a clean Petri
dish containing mineral water and exposed to light to facilitate
hatching of miracidia. Using a binocular microscope, individual
miracidia were then captured in 2–5 ml of mineral water,
pippetted onto Whatman FTA cards and allowed to dry for
1 hour [18].
Individual cercariae from naturally infected snails were also
sampled from a few localities (Table S1). Snails collected from
known transmission sites were placed individually or pooled into
pots of fresh mineral water and exposed to light to stimulate
cercarial shedding. On inspection, using a binocular microscope,
visually identified schistosome cercariae were captured in 2–5 ml of
mineral water, pipetted onto Whatman FTA cards and allowed to
dry for 1 hour.
Laboratory passaged adult worms from nine additional localities
held in the Natural History Museum, London (NHM) liquid
nitrogen schistosome repository, Schistosome Collections at the
Natural History Museum (SCAN), were also utilised for molecular
analysis (Table S1). A feature of the biology of schistosomes
relevant to the use of laboratory passaged samples for molecular
analysis is that there will be a high level of selection or genetic
bottlenecks imposed on the population during the passaging
process and so these samples cannot realistically be treated as
individual samples nor used to represent the true within-locality
variation from these particular isolates [18]. Nevertheless, we
chose to include these additional archived adult worm samples to
increase the geographic range and scope of the current study.
Individual worms sampled from the same laboratory passaged
isolate/NHM number were not treated as individuals, but the
different haplotypes found were used as representative data from
those localities.
DNA extraction and amplification
Whatman FTA stored samples. For genomic DNA (gDNA)
extraction, a 2.0 mm disc containing the sample was removed
from the card using a Harris-Micro-Punch (VWR, UK) and
incubated for 5 mins in 200 ml of FTA purification reagent
(Whatman plc. Maidstone, Kent). The FTA purification reagent
was removed and the disc was incubated for a further 5 mins in
200 ml of fresh FTA purification reagent. This process was
repeated for a total of 3 washes and was followed by 265 mins
incubations in 200 ml of TE buffer. Samples were air dried at 56uC
for 10–30 mins and the disc was visually checked to make sure it
was dry before being used directly in PCR reactions.
Worms held in liquid Nitrogen
Adult worms were thawed on ice and total gDNA was extracted
from individual males and females Table S1, using the DNeasy
Blood and Tissue Kit (Qiagen Ltd, Crawley, UK) and eluted in
100 ml of buffer giving a concentration of 3.6–31.5 ng/ml of gDNA
from each worm, 2 ml of which was used for PCR.
DNA amplification and sequencing
PCR of the partial region of the mitochondrial (mt)
cytochrome oxidase (cox1) gene. For each individual worm,
miracidium or cercaria, 956 bp of the mt cox1 gene was amplified
in separate 25 ml PCR reactions using illustraTM puReTaq
Ready-To-Go PCR Beads (GE Healthcare, UK) and 10 pmol of
each primer (Forward primer: COX1_Schisto_59; Reverse primer;
COX1_Schist_39 [26]. Thermal cycling was performed in a
Perkin Elmer 9600 Thermal Cycler and the PCR conditions used
were: 5 mins denaturing at 95uC: 40 cycles of 30 sec at 95uC,
30 sec at 40uC, 2 mins at 72uC; followed by final extension period
of 7 mins at 72uC. Four mls of each amplicon was visualised on a
0.8% gel-red agarose gel and positive PCR’s were purified using
the QIAquick PCR purification Kit (Qiagen Ltd, UK) and then
sequenced on an 3730XL 96 capillary automated sequencer
(Applied Biosystems, UK) in both directions using 1.6 pmol
dilutions of the original PCR primers and internal sequencing
primers S.haem_cox1_F + S. haem_cox1_R [25] and an Applied
Biosystems Big Dye Kit (V1.1).
PCR of the partial region of the mitochondrial (mt)
NADH-dehydrogenase subunit 1 (nad1) gene. To provide
data from a different mt gene, the partial NADH-dehydrogenase
subunit 1 (nad1) (756 bp) was amplified and sequenced as above
using DNA available from several of the laboratory passaged
samples (Table S1). The primers used were S.haem_nad1_F and
S.haem_nad1_R [25].
Data analysis
mt DNA sequence analysis. All sequences for the different
(cox1 and nad1) datasets were assembled and manually edited using
Sequencher V4.6 (http://genecodes.com) to remove any ambigu-
ities between forward and reverse strands. For each sample
consensus sequences were aligned in Sequencher and polymorphic
positions observed between individuals were checked and
confirmed by visualisation of the original sequence chromato-
grams. The identity (species and gene) of the sequence was also
confirmed using the Basic Local Alignment Search Tool (NCBI-
Blast). Within each individual locality (see locality codes Table S1)
consensus sequences from each individual sample were grouped
and aligned in MacClade 4.05 and then collapsed together using
Collapse V1.2 (http://darwin.uvigo.es/software/collapse.html) to
identify individual samples with identical sequences. Each group of
identical sequences and also any unique sequences became unique
haplotypes for that site and consensus sequences were created and
given a unique haplotype identifier code, consisting of the site code
and a letter representing the different haplotypes within each
locality. The numbers of individuals that presented each haplotype
in each locality were also recorded.
Published mitochondrial data from other isolates of S.
haematobium. Included in our analysis was S. haematobium cox1
and nad1 data available on the NCBI database (http://www.ncbi.
nlm.nih.gov), which was downloaded and incorporated into the
datasets from our collections (Table S1). The Zanzibar S.
haematobium data from Webster et al. [25], was also included in
the analysis.
Haplotype analysis. The complete datasets (sequences of the
unique haplotypes from each locality found in this study and the
published data) were aligned in MacClade 4.05, and then
collapsed (Collapse V1.2 (http://darwin.uvigo.es/software/
cox1 Diversity of Schistosoma haematobium
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collapse.html) to identify any identical haplotypes from different
localities.
Haplotypes that were identical to the most common haplotype
found across Africa (H1, Table S1) were noted. The sequence of
this main (cox1 or nad1) haplotype (H1) was used in the analyses to
represent all the individuals that it corresponded to, unless stated
otherwise. Haplotype sequences were submitted to EMBL/
Genbank (Table S1).
To estimate genealogical relationships between haplotypes, the
individual haplotype sequences were aligned in MacClade V4.05
and then a minimum spanning network was created in the
programme TCS (http://darwin.uvigo.es/software/tcs.html).
cox1 phylogenetic analysis. All the cox1 haplotype sequenc-
es were aligned in MacClade V4.05 and exported into Mega V5
[27]. Evolutionary relationships between the haplotypes were
inferred using the Neighbour-Joining, Maximum Parsimony and
Minimum Evolution methods using the Kimura’s 2-parameter
model (K2P) for pair-wise distance calculations. Analyses were
subjected to 1000 bootstraps to test the reliability of branches of
the trees. The topologies were rooted by the sister species
Schistosoma bovis for which sequence data was obtained, using the
methods described above, from a Senegal isolate that had been
preserved in the NHM liquid nitrogen schistosome repository,
SCAN. To test the topology of the tree further a Maximum
Likelihood (ML) analysis with 500 replicates was also instigated in
Mega V5 using the best fit ML model (HKY+G) which was
calculated in Mega V5 and also by using the Akaike criterion in
jModeltest V0.1.1 [28].
The net nucleotide divergence (Da) between the two main
groups found in this analysis was calculated with the Juke-Cantor
correction model in DnaSP V5.
cox1 population genetic analysis. To analyze the popula-
tion cox1 diversity the sequences from each individual sample were
aligned in MacClade 4.05 and exported into DnaSP V5 [29].
These were then used to calculate haplotype diversity (h) and
nucleotide diversity (P), the latter of which was calculated with
Juke-Cantor corrections, which was the most complex substitution
model available. Overall diversity was measured together with the
diversity within different geographic regions and also each locality
(Tables 1 & 2). All individual miracidia and cercariae were treated
as independent samples and their individual sequences were
incorporated into the analysis. In contrast, for samples obtained
from laboratory passage, and therefore probably highly clonal as
discussed above, only individual worms with different sequences
were used in the analyses. No laboratory passaged samples were
included in the within-locality analysis (Table 2).
Tests of selection. In DnaSP V5 the McDonald_Kreitman
test for selection and Tajima’s test of neutrality were conducted on
our cox1 data to investigate if there was significant selection
occurring.
nad1 phylogentic analysis. Nad1 data was only available
from a subset of the samples from 18 different localities and only
from laboratory passaged worms or previously published data.
Therefore, these data were only analyzed at a basic phylogenetic
level and not the population level. The nad1 haplotypes were
aligned in MacClade V4.05 and exported into Mega V5 [25].
Evolutionary relationships between the haplotypes were inferred
using the Neighbour-Joining method and 1000 bootstraps to test
the reliability of branches of the trees. The topologies were rooted
by the sister species S. bovis as described for the cox1 data.
Analysis of a nuclear marker
To compare variation found within the mtDNA with nuclear
DNA, the complete ITS (1+2) rDNA (927 bp) was amplified from
a single male and a single female worm from all localities that had
representative adult worms available (Table S1). This marker was
amplified and sequenced with the forward and reverse primers
ITS1 + ITS2 [30] using the PCR and sequencing conditions as
used for cox1. In the analysis, published S. haematobium ITS data
were also included from Senegal (FJ588861), Mali (Z21716) and
Zanzibar (GU257398). Sequences were aligned and any nucleo-
tide differences recorded.
Results
Sequence data
There were no differences between the ITS1+2 sequences from
any of the samples. This nuclear marker therefore proved
uninformative as a population genetic marker for S. haematobium.
In total 1978 cox1 sequences were analyzed: 46 from cercariae,
241 from laboratory passaged adult worms (35 published
haplotype sequences from previous studies of which 27 were from
Table 1. Overall and regional cox1 diversity.
Region n u h P
All 1978 61 0.35860.014 0.00435
Mainland Africa 1682 24 0.13960.011 0.00068
Indian Islands*** 296 43 0.92660.009 0.01177
East Africa 197 21 0.82960.020 0.01129
Kenya* 20 1 0 0
Tanzania 23 3 0.17060.102 0.004
Malawi* 5 2 0.40060.237 0.00042
Zambia 71 2 0.02860.027 0.00006
Coastal Kenya 78 15 0.87460.021 0.01216
Egypt* 2 2 1.060.5 0.00113
Sudan* 1 1 0 0
Central West Africa 208 10 0.12160.031 0.00013
Cameroon 207 10 0.12160.031 0.00013
Nigeria* 1 1 0 0
Far West Africa 1353 10 0.02660.006 0.00003
Niger 136 2 0.02960.020 0.00003
Senegal 1211 7 0.02360.006 0.00002
Mali* 3 2 0.66760.314 0.00070
Gambia* 1 1 0 0
Liberia* 1 1 0 0
Guinea Bissau* 1 1 0 0
South Africa* 1 1 0 0
Mauritius* 1 1 0 0
Madagascar* 1 1 0 0
Zanzibar** 214 27 0.89360.013 0.01137
n=number of samples sequenced; u=number of unique haplotypes found
within the region; h=haplotype diversity 6 standard deviation; P=nucleotide
diversity.
*samples form laboratory passaged or pooled larval stages. For these samples
individual worms were not treated as individual samples but instead each
different haplotype found was treated as an individual sample.
**For Zanzibar the whole data set of Webster et al. [25], was used and due to
the high number of worms sampled and high diversity found, individual worms
were treated as individual samples. This was also used in the analysis of the
diversity overall and in the Indian Island region.
***This included samples from Zanzibar, Madagascar, Mauritius and Mafia.
doi:10.1371/journal.pntd.0001882.t001
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214 individual worms isolated from Zanzibar [25] and 1869 from
miracidia collected directly from their human hosts. The cox1
region (956 bp) analyzed contained 70 variable sites (53 parsimony
informative), and the diversity found within the S. haematobium
populations sampled was low with the sequences resolving into just
61 unique haplotypes. The percentage occurrence of each
haplotype varied but there was a main common haplotype (H1)
that was found across most of the localities and appeared
frequently on mainland Africa, representing 1574 (80%) out of
the 1978 overall sequences analyzed.
The minimum spanning TCS network (Figure 1) clearly shows
the dominance of H1 and splits the haplotypes into two groups,
one that is made up of 28 haplotypes from Zanzibar, Coastal
Kenya, Tanzania, Mafia Island, Madagascar and Mauritius and
one that is made up of 46 haplotypes from all localities sampled
excluding Madagascar and Mauritius. The two groups could not
be linked due to too many missing steps: the network for Group 1
is more basic with H1 being a dominant central point from which,
many of the other haplotypes branch off by 1 single step (1 bp
change). This closely linked network, linked by single bp changes,
is made of haplotypes predominantly found in mainland Africa
(except Zambia) and a few haplotypes from Zanzibar. The
majority of these single mutations do not form links with other
haplotypes suggesting that they are random mutations that come
and go but do not persist within the populations. Exceptions to this
are the Egyptian haplotypes, which again branch off from the
main haplotype H1 by one mutation and forms two haplotypes
separated by a single bp change. The other more significant
exceptions are longer branches forming more complicated
networks with haplotypes from Zanzibar and its neighbouring
regions Coastal Kenya and Mafia Island and also samples from
Zambia. Both branches are again closely linked to H1 by single
mutations with one branch also forming links with a Malawi
haplotype and the other incorporates the haplotypes from Zambia.
Group 2 forms a more complicated network between haplotypes
and is more exclusive containing haplotypes from only the Indian
Ocean Islands and the neighbouring East African regions of
coastal Kenya and Tanzania.
Phylogenetic structuring
As with the TCS analysis the same general splitting of the
haplotypes was found with all phylogenetic methods separating the
61 haplotypes into two distinct well-supported groups (Figure 2)
with H1 being central to the majority of the mainland African
haplotypes. The details of all the samples that represent H1 can be
seen in the sub tree in Figure 2. The tree topologies show the
separation of samples from Coastal Kenya, Zanzibar, Mafia Island
and Zambia from the main cluster in Group 1 and also the clear
separation of Group 2 containing samples from the Indian Ocean
Islands and its neighbouring African coastal regions.
The net divergence between the groups (0.0214560.00102)
shows a relatively short time between the genetic separation of
these two S. haematobium groups compared to that of the much
larger divergence from their sister taxa S. bovis (Group 1:
0.1164460.01978, Group 2: 0.1093260.02365)
Population genetics
Measures of overall haplotype and nucleotide diversity, together
with within region and locality diversity, are presented in Tables 1
and 2. Sample numbers will affect the diversity especially when
very low levels of samples are used, however the data do show a
clear difference in diversity between those localities where large
numbers of individual larvae were sampled. The number of
unique haplotypes found in the western regions of Africa
compared to the east is extremely small even though sampling
was biased towards the west and the diversity seen in the east
comes mainly from the coastal Kenyan samples. There is also a
vast contrast, with an extremely high diversity found within the
populations sampled from the Indian Ocean Islands and the
neighbouring coastal regions compared to the rest of Africa, where
one dominant haplotype appears to persist throughout the
mainland. We also tested for strong selection in our data and
found no deviation from neutral expectations (p values were all .
than 0.05).
nad1 S. haematobium data
The nad1 haplotypes sequenced from several of the samples
(Table S1) also supported the findings from the cox1 data (Figure 3).
The haplotypes again split into two distinct groups; 1) dominated
by a central haplotype found throughout mainland Africa and
Zanzibar with a few closely linked haplotypes forming short
branches and a longer branch to the Zambian haplotype and 2)
containing haplotypes from Zanzibar, Madagascar and Mauritius.
Table 2. Within locality cox1 diversity.
Locality* n u h P
Senegal
Nder, SE3 397 2 0.00560.005 0.00001
Temeye, SE4 120 1 0 0
Podor, SE5 104 1 0 0
Tambacounda, SE6 288 2 0.01460.010 0.00001
Kolda, SE7 10 2 0.35660.159 0.00037
Barkedji SE8 288 3 0.05560.019 0.00006
Niger
Libore, NI1 96 2 0.04160.028 0.00004
Falmado, NI2 40 1 0 0
Cameroon
Bessoum, CA1 193 10 0.13060.033 0.00014
Okuro, CA2 10 1 0 0
Kenya
Taveta, KE1 20 1 0 0
Coastal Kenya
Rekeke, CK1 39 8 0.69560.066 0.01207
Kinango. CK2 24 4 0.57660.097 0.00532
Nimbodze, CK3 15 4 0.75260.056 0.00312
Tanzania
Mwanza, TA1 21 2 0.09560.084 0.00243
Zanzibar, Zan 214 27 0.89360.013 0.01200
Zambia
Katunga. ZA2 20 1 0 0
Kafue, ZA3 18 1 0 0
Lisiko, ZA4 32 1 0 0
n=number of samples sequenced; u=number of unique haplotypes found
within the region; h=haplotype diversity 6 standard deviation; P=nucleotide
diversity.
*Only localities where miracidial populations were collected and the data from
Zanzibar [25] were included.
The Genbank Accession numbers for the cox1 data are JQ397330–JQ397399
and for the nad1 data are JQ595387–595404 (see Table S1).
doi:10.1371/journal.pntd.0001882.t002
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Discussion
DNA ‘barcoding’ approaches are now commonly used to
provide insights into population structure and diversity within
species including schistosomes. Studies on S. mansoni have shown
high levels of mtDNA diversity within and between populations
from endemic areas with haplotypes segregating by geography
[23–24].
This study is the first time that DNA cox1 ‘barcoding’ has been
used to elucidate the genetic diversity of S. haematobium populations
across Africa and also from several of the Indian Ocean Islands
(Zanzibar, Madagascar, Mauritius, Mafia). Ninety seven percent
of the data generated came from larval stages sampled directly
from their human hosts from across 20 localities, with the
remainder of the data coming from historical collections based on
laboratory-passaged worms. The study has revealed that the
genetic diversity of S. haematobium across Africa is unexpectedly
low. There were only 61 unique haplotypes found in the 1978
samples collected from 41 locations and 18 countries. The
haplotypes split into two distinct groups; one that contains
haplotypes predominately from mainland Africa with a few
haplotypes from Zanzibar (Group 1) and the other that is made
up of samples exclusively from the Indian Ocean islands and the
neighbouring African coastal regions (Group 2). The net
divergence between the two groups was considerable and was
strongly supported by both the cox1 and the nad1 data. This is
equivalent to the net divergence seen between some S. mansoni
groups spread across Africa, separated by thousands of miles [24].
The lack of the diversity found within and between the S.
haematobium samples can clearly be seen in the TCS network and
phylogenetic analyses with a single haplotype (H1 from 1574
samples) being dominant across Africa with greater diversity found
within the samples from the Indian Ocean Islands and the
neighbouring African coastal regions. The nuclear ITS data
showed no diversity from any sample proving that this can not be
used as a population genetic marker for this parasite [24] although
such a nuclear marker is vital for the detection of interactions with
closely related species and for confirming species identity [31].
The longer branches stemming from the main H1 haplotype in
Group 1 on the TCS analysis show that the populations from
coastal Kenya, Zambia and Mafia are quite separated from the
main haplotype group. The highest diversity was found in the S.
haematobium populations from coastal Kenya and Zanzibar with
complicated networks linking these haplotypes and several nodes
not being represented by a haplotype. This suggests that
haplotypes may have become extinct or that they have not been
sampled indicating there may be more diversity still to be
discovered in these areas. However, the basic network of single
links around H1 suggests that further sampling in the other areas,
reported on in this study, is unlikely to reveal further discrete
groupings. With exceptions of haplotypes from the Indian Ocean
Islands, Coastal Kenya and Zambia, the network clearly shows a
lack of geographic structuring with the same cox1 haplotypes being
found in Far West, Central West, East, South of Africa and also in
Sudan, Egypt and Zanzibar.
The distribution of the haplotypes must reflect in part past
movements of people. Group I and 2 parasites have been isolated
from the same geographical regions and from the same host. For
example, the haplotypes from Mwanza, Tanzania (TA1a + b),
resolve into both network groups, one haplotype (TA1a) being
identical to the H1 haplotype (Group 1) and one (TA1b) being
identical to a haplotype found on Mafia Island and sitting at the
Figure 1. Minimum spanning TCS networks incorporating all the cox1 haplotypes analyzed in this study. Each line between haplotypes
represents a single bp change and small circles between lines represent unsampled or extinct haplotypes. The network forms 2 distinct groups of
haplotypes that cannot be linked. Group 1 is a simple network containing the main land African samples and a few of the Indian Ocean Island
samples. The majority of the samples are closely clustered around the main haplotype (H1) by separate single links representing a single polymorphic
position. There are 2 longer branches, ‘‘blue star’’, leading off from the main cluster to form networks between Zanzibar, Coastal Kenya, Tanzania
(+Mafia) and Zambian samples. H1 represents samples from 29 out of the 43 separate localities and represents 1574 out of the 1978 sequences
analyzed (see figure 2 for the list of haplotype codes that represent H1). Group 2 forms a more complicated network containing the majority of the
samples from the Indian Ocean Islands and samples from the closely located areas of Coastal Kenya and Tanzania. Identical haplotypes are grouped
in the same oval.
doi:10.1371/journal.pntd.0001882.g001
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end of a long branch within Group 2. This suggests that in this
geographic region as well as the main dominant S. haematobium
genotype there has also been transfer of Group 2 schistosomes
from the Indian Ocean Islands and the neighbouring coastal
regions probably associated with the movements of people [32].
Similarly, the positioning of the Mafia haplotypes (Mafia1 + 2) in
the two groups shows the close affinity of this population with S.
haematobium from Zanzibar. This is not unexpected due to infected
children from Mafia having a travel history to the Zanzibar
mainland and that urogenital schistosomiasis is suggested to be
imported and not endemic on Mafia.
The higher diversity found in the coastal Kenyan populations
(15 haplotypes), the close clustering with the Zanzibar haplotypes
and the separation of these populations into the two groups also
Figure 2. Neighbour-joining cox1 tree topology. Nodal supports for the 2 groups are marked and details of the samples representing H1, ‘‘red
dot’’, are shown in the sub tree. Each terminal branch is labelled with the individual haplotype codes as detailed in Table S1.
doi:10.1371/journal.pntd.0001882.g002
Figure 3. Neighbour-joining nad1 tree topology supporting the topology of the cox1 tree. Nodal supports for the 2 groups are marked
and details of the samples representing H1, ‘‘red dot’’, are shown in the sub tree. Each terminal branch is labelled with the individual haplotype codes
as detailed in Table S1.
doi:10.1371/journal.pntd.0001882.g003
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suggests a close association between parasites from coastal Kenya
and Zanzibar. There is probably mixing and movements of the
populations between coastal Kenya and Zanzibar and vice versa
with the movements of people between these areas due to the trade
routes between the Indian Ocean islands and the neighbouring
East African coastal regions [32]. The positioning of the
haplotypes from Madagascar and Mauritius in Group 2 further
supports the uniqueness of the haplotypes from the Indian Ocean
Islands and neighbouring East African coastal regions compared
to those from mainland Africa. The recognition and distribution of
Group 2 schistosomes suggests movement of S. haematobium
populations from endemic adjacent regions such as Madagascar
and the Arabian Peninsula. There is a history of prolific trade links
between the Arabian Peninsula, India, the Indian Ocean Islands
and the East coast of Africa aided by the Monsoon trade winds,
which probably would have facilitated the movements of people
and their parasites between these areas.
In consideration of general population genetic theories, the
extremely low levels of genetic diversity between the S. haematobium
populations separated by 1000’s of miles across continental Africa
compared to the high diversity found within the populations from
the more isolated Indian Ocean Islands and their closely
neighbouring African coastal regions is unexpected. It is partic-
ularly striking that the dominant haplotype H1 occurs across
Africa with 1574 samples analyzed not showing a single nucleotide
mutation in the mtDNA analyzed. The success of this haplotype
might be attributed to a founder effect following a population
‘bottleneck’ with only a few individual parasites surviving and
participating in a later population expansion. The lack of diversity
found across Africa and the restriction of the Group 2 haplotypes
to coastal regions of East Africa and the Indian Ocean Islands
suggests that this may have happened relatively recently in terms
of the evolutionary history of these parasites. Given the close
phylogenetic relationship of the Indian/Asian and African
Schistosoma species [33–34] it is possible that the lack of genetic
diversity found within and between the S. haematobium populations
across mainland Africa is attributed to a re-invasion by a small
number of individuals of S. haematobium into Africa from a larger
population in Asia across the Arabian peninsula, with a
subsequent rapid spread and population expansion across Africa
from East to West. The new small re-established population in
Africa would be more sensitive to genetic drift and increased
inbreeding resulting in low genetic variation. Due to the lack of
fossil records it is extremely difficult to accurately define the
evolutionary history and phylogeography of the Schistosoma genus
[24], [34–35] however, data such as that reported here do provide
new insights into how these parasites evolved and spread and c
learly it will be of interest to barcode samples from the Arabian
Peninsula.
One factor that could have influenced the divergence of our
populations into the two groups relates to compatibility with
intermediate snails hosts. Intermediate host use of S. haematobium is
very specific and varies in different geographical locations [6].
However, based on current day snail distributions there is no
obvious correlation between intermediate host use and the
observed parasite diversity. S. haematobium in East Africa and the
Indian Ocean Islands is mainly transmitted by Bulinus africanus and
B. forskalii group species while elsewhere the same species groups
can be involved but snails of the B. truncatus tropicus complex may
also play an important role in transmission. However, the study by
[36] did show that the intermediate snail host, B. globosus, separates
into distinct West and East African clades on a molecular
phylogenetic tree, possibly suggesting that the distribution of East
African B. globosus could be a limiting factor in the spread of Group
2 type parasites. It is clear that more studies are needed to
investigate the role of the different snail species and geographical
populations of Bulinus in the transmission of Group 1 and Group 2
type parasites. As well as intermediate snail host compatibility it
will be important to determine whether the different groups give
rise to infections which result in different pathologies or which
respond differently to treatments as genetic diversity has been
noted to possibly have an effect on such characteristics [37].
Though the small regions of nuclear DNA analyzed in this study
proved highly conserved, it is likely that there could be more
diversity found in other regions of the nuclear genome, which may
or may not correlate to that found in the mt DNA. A recent study
[8], using a small number of microsatellite markers did find
diversity in S. haematobium miracidial populations from Mali
conflicting the data presented here, however only laboratory
maintained material from Mali was analysed in the present study
and so a direct comparison cannot be made. Due to the difficulties
in directly sampling natural schistosome populations there exists a
strong sampling bias within this study with the majority of the data
obtained from large larval schistosome populations collected from
6 countries. The other countries are represented by far fewer or
laboratory maintained samples and whilst providing useful genetic
data it cannot be concluded that they are representative of the true
genetic diversity in these countries. More samples need to be
analyzed from more areas and with more genetic markers to
further elucidate the genetic diversity of S. haematobium populations
from all it’s endemic areas. It would also be beneficial to analyze
both nuclear and mt DNA simultaneously from the same
individual sample in future population genetic studies and the
recent publication of whole-genome sequence of an Egyptian
isolate of S. haematobium [5] will facilitate the development of many
more nuclear markers for population genetic analyses at the
genomic level.
The genetic diversity of schistosome populations can be
influenced by a variety of factors such as; host water-contact
patterns, host immunity and susceptibility and moreover, mass
chemotherapy has a great potential to promote selection. [15], [8].
The impact of the large-scale administration of PZQ, through
national control programmes [11–12] on the genetic selection of
both S. mansoni and S. haematobium is an area of high interest with
respect to the development of drug resistance [38–40], [14–15],
[41]. A high population diversity would be expected to provide a
wide genetic base for selection to act upon possibly increasing the
rate of resistance to treatment developing, ultimately resulting in a
decline in diversity over time to a few, non susceptible genotypes
[42]. The relatively low level of diversity within S. haematobium
across most of mainland Africa, as defined by the current genetic
markers, may indicate that these parasites may be less likely to
change under drug pressure, however the high genetic diversity
found on Zanzibar and the neighbouring African coastal region
could offer a genetic base for the development of PZQ resistance
and hence changes in parasite diversity in relation to chemother-
apy needs to be monitored in these highly diverse areas.
This study has reported on some very unusual findings in
relation to S. haematobium mtDNA population genetics. It is clear
that further sampling in many areas will not dramatically increase
the mtDNA diversity found but in areas such as Zambia, the East
African coastal regions and the Indian Ocean islands where more
diverse populations of S. haematobium have been found, further
sampling would add to our understanding of the parasite
population movements and diversity. It is also important that
the population genetics of the S. haematobium is monitored further
to link diversity with morbidity and to provide information on the
response of parasite populations to drug treatment pressures. The
cox1 Diversity of Schistosoma haematobium
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mtDNA diversity described here, together with other molecular
markers, will be of value to monitor the impact of control
interventions on different S. haematobium genotypes and may assist
in understanding the introduction or re-introduction of parasites
associated with human population movements.
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